Two Canadian medical marijuana groups, which include most of the country’s top cultivators, have teamed up to address critical issues affecting businesses and patients across the country with a united voice.
Cannabis Canada Association, which counts close to 60 of Canada’s 102 licensed producers as members, including industry-leader Canopy Growth, partnered with the Canadian Medical Cannabis Council to create the Cannabis Canada Council.
Allan Rewak was appointed executive director of the reorganized industry body. Rewak previously served as vice chair of the Cannabis Canada Association and a partner for consulting firm Pathway Group.
“By sharing our common resources, by sharing our thoughts, we can come up with better policy. That’s going to help the government and the cannabis community better understand how we can work together toward our common objectives,” Rewak told Marijuana Business Daily.
Some areas the group will focus on are the controversial excise tax on medical cannabis and supply chain issues.
“We want to preserve the medical system, we want to remove excise tax on legitimate medical cannabis, and we want to ensure that product differentiation and education can occur,” Rewak said.
Cannabis Canada added three main committees to focus on medical and recreational cannabis:
- The medical committee will be led by Philippe Lucas, vice president of British Columbia-based Tilray.
- The adult-use committee will be headed by John Fowler, CEO of Toronto-based Supreme Cannabis Co.
- Another committee will focus on public affairs.
Matt Lamers can be reached at email@example.com
To sign up for our weekly Canada marijuana business newsletter, click here.